Mayne Pharma Investor Relations Material
Latest events
AGM 2024
Mayne Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Mayne Pharma Group Limited
Access all reports
Mayne Pharma Group Limited is an Australian pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic pharmaceutical products. The company’s portfolio spans various therapeutic areas, including women’s health, dermatology, and pain management, with products available in oral, topical, and injectable forms. Mayne Pharma operates manufacturing facilities in Australia and the United States, and its services include contract development and manufacturing for other pharmaceutical companies. The company is headquartered in Salisbury, South Australia, and its shares are listed on the Australian Securities Exchange.
Key slides for Mayne Pharma Group Limited
H2 2024
Mayne Pharma Group Limited
H2 2024
Mayne Pharma Group Limited
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
MYX
Country
🇦🇺 Australia